In the past few years, public understanding of NAD+ has largely focused on "supplementation"-supplementing NMN, NR, and NAD+ itself, as if simply flooding the body with these molecules could violently reverse the aging clock.
This thinking is strikingly similar to the health supplement logic of 20 years ago: supplement calcium if you're deficient, supplement iron if you're deficient, and stuff whatever you're lacking. Yes, that's not wrong, but what's missing?
Simply put, NAD+ isn't a calcium supplement. It's a core hub molecule distributed throughout the body, participating in hundreds of biochemical reactions. Indiscriminately increasing its level in the blood is like simultaneously pressurizing the water pipes of an entire building-some rooms need it, some might burst, and some don't need that much water at all.
The "next stop" for NAD+ research has long since shifted from "how to increase levels" to "how to ensure NAD+ is present in the right place at the right time, and functions in the right way." In short, it's an evolution from "mindless supplementation" to "precise navigation."
I. Why can't we "mindlessly supplement" anymore?
Let's look at two real-world dilemmas.
Dilemma 1: Overall improvement doesn't equal targeted benefit.
When you take NMN or NR orally, NAD+ levels increase systemically through blood circulation.
However, if you want to combat brain aging, most of the NAD+ is retained by the liver and muscles; if you want to repair heart mitochondria, most goes to the kidneys and intestines.
Dilemma 2: Different cells and different states have completely different NAD+ needs.
When immune cells are activated, they require large amounts of NAD+ to support explosive energy consumption and signal transmission; while resting neurons only need to maintain a basic level. The brains of a healthy middle-aged person and an elderly person with neurodegenerative diseases have drastically different NAD+ needs, distribution patterns, and metabolic rates.
Using the same approach to deal with vastly different physiological scenarios is inefficient, and even risky.
Therefore, the consensus shift in academia over the past five years has been from "supplementary dosage" to "spatiotemporal precision."
II. The First Layer of Precise Navigation: Targeted Delivery-Equipping NAD+ with a "Navigation Map"
If we compare NAD+ to an ambulance, the old approach was to dump it onto a city main road and let it wander aimlessly. "Targeted delivery" is like equipping the ambulance with real-time navigation, telling it: turn left to the mitochondria, turn right to cross the blood-brain barrier, or go straight to immune cells.
Currently, the three most popular targeting pathways are:
① Mitochondrial Targeting: "Dedicated" to the Energy Factory
Mitochondria are the largest consumers of NAD+ because they are responsible for energy production. However, mitochondria have two membranes, making it more difficult for NAD+ to enter than to enter the cell. A cutting-edge strategy is to "graft" a mitochondrial-targeting sequence onto the NAD+ precursor, allowing the precursor to preferentially accumulate inside the mitochondria.
This technology has been shown in mouse experiments to significantly improve age-related decline in muscle mitochondrial function.
② Brain Targeting: Breaking Through the Blood-Brain Barrier
The blood-brain barrier is a natural defense protecting the brain, but it also blocks 99% of drugs. Scientists are experimenting with encapsulating NAD+ or NMN in nanoliposomes or exosomes. These tiny "capsules" can disguise themselves as nutrients needed by the brain, sneaking into the central nervous system.
Once this breakthrough is achieved, it will provide a completely new tool for the adjunctive intervention of neurodegenerative diseases such as Alzheimer's and Parkinson's.
③ Immune Cell Targeting: Precisely Regulating the Aging Immune System
A major characteristic of aging is "immunoaging"-immune cells become sluggish, and inflammatory factors are excessively released. Directing NAD+ to aging-related T cells or macrophages is expected to reshape their metabolic state, making the immune system more sensitive and balanced again.
III. The Second Layer of Precise Navigation: Next-Generation Precursors-"Smart Keys" Replacing "Master Keys"
NMN and NR are first-generation precursors, belonging to the category of "master keys"-they can open any door, but which door to open, for how long, and how wide is uncontrollable. The design philosophy for next-generation precursors is completely different: endowing precursor molecules with additional "smart switches."
Direction 1: Tissue-Preferenced Precursors.
Through computer-aided design and structural modification, researchers are screening precursor derivatives that can be preferentially recognized by transport proteins in specific organs. For example, adding a "liver-targeting group" to a precursor molecule makes it preferentially taken up by the liver; adding a "brain-targeting peptide" makes it easier to cross the blood-brain barrier.
Direction 2: Precursor "Combination Punch."
Different precursors enter cells through different channels and transformation pathways. NMN mainly enters cells through a transport protein called Slc12a8, while NR enters through another channel. The future will not be about consuming a single precursor, but about designing dynamic ratios of multiple precursors according to different physiological scenarios-using combination A after exercise, combination B before sleep, and combination C for postoperative recovery, achieving "1+1>2."
IV. The Third Layer of Precision Navigation: System Regulation-From "Adding Water" to "Repairing Pipelines"
The highest level of precision is not about supplementing external resources, but about modifying the internal system.
Gene-level regulation: Using gene-editing tools like CRISPR, researchers can directly edit genes that regulate NAD+ synthases or degradation enzymes. For example, enhancing the activity of NMNAT enzymes (efficiently converting NMN into NAD+) or inhibiting the activity of CD38 enzymes (CD38 is the biggest "vampire" of NAD+ consumption).
Cell-level engineering: Infusing genetically engineered cells-such as stem cells or immune cells highly expressing NAD+ synthase systems-allows them to become "miniature NAD+ production workshops" within the body, producing and supplying NAD+ where needed.
This sounds like science fiction, but cell therapy has already made breakthroughs in oncology and rare diseases; its application to NAD+ is only a matter of time.
Conclusion: The romance of science lies in the shift from "addition" to "multiplication."
The logic of "mindless supplementation" is addition: add what's missing-simple and crude.
The logic of "precise navigation" is multiplication: understanding the system, respecting rhythms, minimal intervention, and maximum effect.
The next step in NAD+ research isn't finding a magical new molecule, but rather an upgrade of an entire epistemological and methodological framework-we no longer view the body as a container that needs constant filling, but as a meticulously woven network. We no longer ask, "How do we get NAD+ in?" but rather, "How do we ensure NAD+ is in the right place, at the right time, doing the right thing?"
The road is long, but the direction is clear. As an industry player, Invertin is doing more than just producing high-quality NAD+ raw materials today-it's investing in potentially game-changing technology platforms: synthetic biology, green enzyme catalysis, targeted delivery carriers… These seemingly distant endeavors will ultimately become the most solid foundation when the era of "precision navigation" arrives.
